pidotimod has been researched along with Morbid Obesity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falasca, K; Moffa, L; Moffa, S; Ucciferri, C; Vecchiet, J | 1 |
1 other study(ies) available for pidotimod and Morbid Obesity
| Article | Year |
|---|---|
Are monoclonal antibodies effective in patients with severe obesity in SARS-CoV-2 infected?
Topics: Antibodies, Monoclonal; Cholecalciferol; COVID-19; Humans; Obesity; Obesity, Morbid; SARS-CoV-2 | 2023 |